
76.20 Delayed Data As of Jun 01 | ![]() Today’s Change | 57.17 Today|||52-Week Range 89.74 | -11.24% Year-to-Date |
The 23 analysts offering 12-month price forecasts for Gilead Sciences Inc have a median target of 90.00, with a high estimate of 115.00 and a low estimate of 77.00. The median estimate represents a +18.11% increase from the last price of 76.20.
The current consensus among 30 polled investment analysts is to Hold stock in Gilead Sciences Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.